Exemestane

Back to search

Molecule Structure

Scientific Name

Exemestane

Description of the Drug

Exemestane is an aromatase inhibitor used to treat breast cancer in postmenopausal women after treatment with tamoxifen.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00990

Brand Name(s)

Aromasin, Exemestane

Company Owner(s)

Cipla Ltd, Breckenridge Pharmaceutical Inc, Qilu Pharmaceutical Co Ltd, Alvogen Inc, Mayne Pharma Inc, Upsher Smith Laboratories Llc, Eugia Pharma Specialities Ltd, Amneal Pharmaceuticals Of New York Llc, Zydus Pharmaceuticals Usa Inc, Hikma Pharmaceuticals Usa Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Cytochrome P450 19A1 SINGLE PROTEIN INHIBITOR CHEMBL1978

Unichem Links

Atlas exemestane
SureChEMBL SCHEMBL6215
PharmGKB PA449563
Human Metabolome Database HMDB0015125
DrugBank DB00990
PubChem: Thomson Pharma 14922734 14898201
PubChem 60198
LINCS LSM-5474
Nikkaji J367.471A
PDBe EXM
BindingDB 50398447
EPA CompTox Dashboard DTXSID5023037
DrugCentral 1122
ChemicalBook CB5760314
Guide to Pharmacology 7073
rxnorm EXEMESTANE AROMASIN
PubChem: Drugs of the Future 12014009
ChEBI 4953
ZINC ZINC000003973334